Reaction
Eczema Nummular reporting signals
As of the last recalculation, Eczema Nummular appears in 458 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is NEMOLIZUMAB-ILTO (PRR 78.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nemolizumab-Ilto | 21 | 78.6 | 78.8 |
| Ganciclovir | 9 | 40.7 | 40.8 |
| Ganciclovir Sodium | 9 | 39.4 | 39.4 |
| Dupilumab | 97 | 11.3 | 11.3 |
| Guselkumab | 6 | 7.7 | 7.7 |